FAVIPIRAVIR 200MG/400 MG/800MG

About FAVIPIRAVIR 200MG/400 MG/800MG

Favivir improves treatment accessibility to a significant amount of Covid 19 patient population, who usually sustain mild to moderate symptoms. The product is available at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription.

Effective Management of Mild to Moderate COVID-19

Favipiravir is designed to help adults combat mild to moderate symptoms of COVID-19 by targeting viral replication. This antiviral offers a valuable option for patients under medical supervision, providing timely intervention during the early stages of infection. Supplied in convenient tablet form, it is suitable for use at home under strict medical guidance. Each dose is calibrated for optimum impact while prioritizing patient safety.


Strict Prescription Guidelines and Dosage Adherence

Favipiravir should only be taken under strict medical supervision. The dosage and frequency are determined by the prescribing physician based on clinical presentation and individual needs. To ensure safe and effective therapy, it is vital for patients to take the medication at the same time every day and not to skip doses. The treatment duration is specific to each patient and should never be adjusted without medical consultation.


Safety Precautions and Storage Instructions

Favipiravir must be stored in a cool, dry environment below 30C and kept away from light to preserve its efficacy. Special care must be taken to avoid its use in pregnant or breastfeeding women unless specifically recommended by a physician. Maintaining medicine safety helps minimize risk and ensures that the medication retains its therapeutic benefits throughout its shelf life.